SYNTHEXA
Home/Products/AOD-9604
AOD-9604 — SYNTHEXA
GMP Certified
HPLC Verified
COA Included
EU Compliant
Performance>99.1% Purity

AOD-9604

Lipolytic HGH Fragment

C-terminal fragment (residues 176-191) of human growth hormone. Retains the lipolytic activity of HGH — stimulating fat breakdown and inhibiting lipogenesis — without binding GH receptors or affecting IGF-1 or insulin levels.

Format

5mg / vial

Purity

>99.1%

Category

Performance

Storage

2–8 °C

Research Price

79

5mg / vial

Ask a Question

RESEARCH USE ONLY

This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.

SYNTHEXA Pen Kit
RECOMMENDED DELIVERY SYSTEM

Complete Your Research with the Pen Kit

Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.

189

View details →
FREQUENTLY RESEARCHED TOGETHER

Research Protocol Bundles

Metabolic Research Stack

Semaglutide + AOD-9604 + Fragment 176–191

A three-compound metabolic protocol combining GLP-1 receptor agonism (Semaglutide) with the two most studied lipolytic peptide fragments for body-composition research.

Semaglutide149
AOD-960479
Fragment 176-19169

Bundle total

297

10% bundle saving

IMPORTANT RESEARCH DISCLAIMER

This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA™ assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.